Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction

Stroke

Volumn 30, Issue 8, 1999, Pages 1577-1582

  Pereira, Anthony C ^b   Saunders, Dawn E ^b   Doyle, Victoria L ^b   Bland, J Martin ^b   Howe, Franklyn A ^b   Griffiths, John R ^b   Brown, Martin M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Institute of Neurology ^*

Author keywords

Human; Outcome; Spectroscopy, nuclear magnetic resonance; Stroke

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN METABOLISM; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOMES RESEARCH; PRIORITY JOURNAL; STROKE;

EID: 0032797714     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.8.1577     Document Type: Article

References (34)

1. Bonita R, Stewart AW, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke. 1990;21:989-992.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1996;333:1581-1587.
3. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342:395-398.
4. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-1159.
5. Howe FA, Maxwell RJ, Saunders DE, Brown MM, Griffiths JR. Proton spectroscopy in vivo. Magn Reson Q. 1993;9:31-59.
6. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981-989.
7. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem. 1992;59: 55-61.
8. Miller BL. A review of chemical issues in 1-H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991;4:47-52.
9. 1H-MRS demonstration of the ischaemic penumbra in man. Proc Int Soc Magn Reson Med. 1998:1147. Abstract.
10. Arnold DL. Reversible reduction of N-acetyl aspartate after acute central nervous system damage. Proc Int Soc Magn Reson Med. 1992:643. Abstract.
11. Graham GD, Blamire AM, Howseman AM, Rothman DL, Fayad PB, Brass LM, Petroff OA, Shulman RG, Prichard JW. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke. 1992;23:333-340.
12. Saunders DE, Clifton AG, Brown MM. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. Stroke. 1995; 26:2272-2276.
13. Lindenstrom E, Boysen G, Christiansen LW, Hansen BR, Nielson PW. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis. 1991;1:103-107.
14. Urenjak J, Obrenovitch TP, Richards D, Williams SR, Symon L. Is N-acetyl-aspartate involved in neurotransmission? A microdialysis study. In: Rollema H, Westerink B, Drijhof WJ, eds. Monitoring Molecules in Neuroscience. Groningen, Germany: University Center for Pharmacy; 1991:355-357.
15. Bentley MD, Karwoski RA. Estimation of tissue volume from serial tomographic sections: a random statistical marker method. Invest Radiol. 1988;10:742-747.
16. Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med. 1989;11:47-63.
17. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd R. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med. 1994;31:365-373.
18. 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med. 1988;6:92-98.
19. Pijnappel WWF, van den Boogart A, de Beer R, van Ormondt D. SVD-based quantification of magnetic resonance signals. J Magn Reson. 1992;97:122-134.
20. 1H magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in Signal Processing III. Oxford, UK: Clarendon Press; 1994:175-195.
21. Norton WT, Poduslo SE, Suzuki K. Subacute sclerosing leukoencephalitis, II: chemical studies including abnormal myelin and abnormal ganglioside pattern. J Neuropathol Exp Neurol. 1966;25:582-597.
22. Blamire AM, Graham GD, Rothman DL, Prichard JW. Proton spectroscopy of human stroke: assessment of transverse relaxation times and partial volume effects in single volume steam MRS. Magn Reson Imaging. 1994;12:1227-1235.
23. Saunders DE, Howe FA, van den Boogaart A, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 1995;26:1007-1013.
24. 1H MRS of stroke. Neurology. 1992;42:1408-1412.
25. Wardlaw JM, Marshall I, Wild JM, Dennis MS, Cannon J, Lewis SC. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurologic deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke. 1998;29:1618-1624.
26. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. J Cereb Blood Flow Metab. 1981;1:297-311.
27. Siesjo BK. Acidosis and ischemic brain damage. Neurochem Pathol. 1988;9:31-88. Review.
28. Siemkowicz E, Gjedde A. Post-ischemic coma in rat: effect of different pre-ischemic blood glucose levels on cerebral metabolic recovery after ischemia. Acta Physiol Scand. 1980;110:225-232.
29. Myers RE. Lactic acid accumulation as cause brain edema and cerebral necrosis resulting from oxygen deprivation. In: Korobkin R, Guilleminault C, eds. Advances in Perinatal Neurology. New York, NY: Spectrum; 1979:85-114.
30. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat, I: local cerebral blood flow and glucose utilization. Stroke. 1980;11:347-354.
31. Kalimo H, Rehncrona S, Soderfeldt B, Olsson Y, Siesjo BK. Brain lactic acidosis and ischemic cell damage, 2: histopathology. J Cereb Blood Flow Metab. 1981;1:313-327.
32. Graham GD, Blamire AM, Rothman DL, Brass LM, Fayad PB, Petroff OAC, Prichard JW. Early temporal variation of cerebral metabolites after human stroke: a proton magnetic resonance spectroscopy study. Stroke. 1993;24:1891-1896.
33. Gideon P, Sperling B, Arlien-Soborg P, Olsen TS, Henriksen O. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke. 1994;25:967-973.
34. van Gijn J. Measurement of outcome in stroke prevention trials. Cerebrovasc Dis. 1992;2:23-34.